• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血色病患者的研究重点:提高生活质量。

Haemochromatosis patients' research priorities: Towards an improved quality of life.

机构信息

Department of Basic Sciences, Iron metabolism: Regulation and Diseases, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, Spain.

Group of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.

出版信息

Health Expect. 2023 Dec;26(6):2293-2301. doi: 10.1111/hex.13830. Epub 2023 Jul 28.

DOI:10.1111/hex.13830
PMID:37503783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10632644/
Abstract

BACKGROUND

Chronic diseases are associated with a range of functional and psychosocial consequences that can adversely affect patients' quality of life (QoL). Haemochromatosis (HC) is a genetically heterogeneous disorder characterized by chronic iron overload that can ultimately lead to multiple organ dysfunction. Clinical diagnosis remains challenging due to the nonspecificity of symptoms and a lack of confirmatory genotyping in a substantial proportion of patients. Illness perception among HC patients has not been extensively investigated, lacking relevant information on how to improve their QoL.

METHODS

We present the results of the first worldwide survey conducted in nearly 1500 HC respondents, in which we collected essential demographic information and identified the aspects that concern HC patients the most.

RESULTS

Out of all the participants, 45.3% (n = 676) voiced their concern about physical and psychological consequences such as HC-related arthropathies, which can ultimately affect their social functioning. A similar proportion of patients (n = 635, 42.5%) also consider that better-informed doctors are key for improved HC disease management. Taking a patient-centred approach, we expose differences in patients' disease perspective by social and economic influences.

CONCLUSIONS

We identify potential targets to improve patients' health-related QoL and reflect on strategic measures to foster gender equity in access to health resources. Finally, we make a call for a highly coordinated effort across a range of public policy areas to empower participants in the HC research process and design.

PATIENT OR PUBLIC CONTRIBUTION

Nearly 1500 patients with hereditary HC responded to an anonymized online survey in which research and clinical priorities were addressed regarding this chronic and rare disease.

摘要

背景

慢性病与一系列功能和心理社会后果相关,这些后果可能会对患者的生活质量(QoL)产生不利影响。血色病(HC)是一种遗传性异质性疾病,其特征为慢性铁过载,最终可导致多器官功能障碍。由于症状缺乏特异性且相当一部分患者缺乏确认性基因分型,临床诊断仍然具有挑战性。HC 患者的疾病认知尚未得到广泛研究,缺乏有关如何改善其生活质量的相关信息。

方法

我们介绍了首次在近 1500 名 HC 应答者中进行的全球调查结果,在该调查中,我们收集了重要的人口统计学信息,并确定了最令 HC 患者关注的方面。

结果

在所有参与者中,45.3%(n=676)表示担心 HC 相关的关节病等身体和心理后果,这些后果最终可能会影响他们的社交功能。同样比例的患者(n=635,42.5%)也认为,更好地了解疾病的医生是改善 HC 疾病管理的关键。我们采取以患者为中心的方法,根据社会和经济影响,揭示患者对疾病的不同看法。

结论

我们确定了改善患者健康相关生活质量的潜在目标,并思考了促进卫生资源获取方面性别平等的战略措施。最后,我们呼吁在一系列公共政策领域进行高度协调的努力,赋予 HC 研究过程和设计的参与者权力。

患者或公众贡献

近 1500 名遗传性 HC 患者对一项匿名在线调查做出了回应,该调查涉及针对这种慢性和罕见疾病的研究和临床重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2916/10632644/e0d922d381c7/HEX-26--g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2916/10632644/e0d922d381c7/HEX-26--g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2916/10632644/e0d922d381c7/HEX-26--g001.jpg

相似文献

1
Haemochromatosis patients' research priorities: Towards an improved quality of life.血色病患者的研究重点:提高生活质量。
Health Expect. 2023 Dec;26(6):2293-2301. doi: 10.1111/hex.13830. Epub 2023 Jul 28.
2
Interventions for hereditary haemochromatosis: an attempted network meta-analysis.遗传性血色素沉着症的干预措施:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 8;3(3):CD011647. doi: 10.1002/14651858.CD011647.pub2.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
5
Worldwide policies on haemochromatosis and blood donation: a survey among blood services.全球范围内的血色素沉着病和献血政策:血液服务机构的调查。
Vox Sang. 2013 Aug;105(2):121-8. doi: 10.1111/vox.12038. Epub 2013 May 11.
6
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
7
Psychosocial Resources and Quality of Life in Transgender Women following Gender-Affirming Surgery.跨性别女性接受性别肯定手术后的心理社会资源与生活质量。
J Sex Med. 2019 Oct;16(10):1672-1680. doi: 10.1016/j.jsxm.2019.08.007.
8
Genetic hemochromatosis: Pathophysiology, diagnostic and therapeutic management.遗传性血色素沉着症:病理生理学、诊断与治疗管理
Presse Med. 2017 Dec;46(12 Pt 2):e288-e295. doi: 10.1016/j.lpm.2017.05.037. Epub 2017 Nov 20.
9
Hereditary hemochromatosis: An update vision of the laboratory diagnosis.遗传性血色素沉着症:实验室诊断的最新视角。
J Trace Elem Med Biol. 2023 Jul;78:127194. doi: 10.1016/j.jtemb.2023.127194. Epub 2023 May 6.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Quantitative and qualitative analysis of quality of life in people diagnosed with genetic haemochromatosis in the United Kingdom.英国遗传性血色素沉着症患者生活质量的定量与定性分析
J Patient Rep Outcomes. 2025 Jul 29;9(1):96. doi: 10.1186/s41687-025-00865-6.
2
The Genetic Diagnostics of Hemochromatosis: Disparities in Low- Versus High-Income Countries.血色素沉着症的基因诊断:低收入国家与高收入国家的差异
Cureus. 2024 Jul 8;16(7):e64074. doi: 10.7759/cureus.64074. eCollection 2024 Jul.

本文引用的文献

1
Analysis of Hand Joint Space Morphology in Women and Men with Hereditary Hemochromatosis.遗传性血色素沉着症患者的男女手部关节间隙形态分析。
Calcif Tissue Int. 2023 Apr;112(4):440-451. doi: 10.1007/s00223-022-01050-3. Epub 2023 Feb 4.
2
Chronic diseases and productivity loss among middle-aged and elderly in India.印度中老年人群的慢性病与生产力损失。
BMC Public Health. 2022 Dec 16;22(1):2356. doi: 10.1186/s12889-022-14813-2.
3
Hemochromatosis classification: update and recommendations by the BIOIRON Society.血色病分类:BIOIRON 学会的更新和建议。
Blood. 2022 May 19;139(20):3018-3029. doi: 10.1182/blood.2021011338.
4
Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.2019冠状病毒病大流行对资源匮乏地区慢性病护理随访的影响及当前观点:一项叙述性综述
Int J Physiol Pathophysiol Pharmacol. 2021 Jun 15;13(3):86-93. eCollection 2021.
5
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators.铁在 COVID-19 发病机制中的作用及乳铁蛋白和其他铁螯合剂的可能治疗作用。
Biomed Pharmacother. 2021 Apr;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13.
6
A comparison of platelet quality between platelets from healthy donors and hereditary hemochromatosis donors over seven-day storage.健康供者与遗传性血色素沉着症供者血小板在 7 天储存期内血小板质量的比较。
Transfusion. 2021 Jan;61(1):202-211. doi: 10.1111/trf.16176. Epub 2020 Nov 9.
7
Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19.遗传性血色素沉着症、噬血细胞性淋巴组织细胞增生症与新型冠状病毒肺炎
Clin Infect Pract. 2020 Oct;7:100052. doi: 10.1016/j.clinpr.2020.100052. Epub 2020 Nov 1.
8
The Perfect Balance? Managing Heavy Menstrual Bleeding and Dysmenorrhea in a Patient with Hereditary Hemochromatosis and von Willebrand Disease.完美平衡?遗传性血色素沉着症和血管性血友病患者的月经过多和痛经管理。
J Pediatr Adolesc Gynecol. 2021 Feb;34(1):74-76. doi: 10.1016/j.jpag.2020.10.003. Epub 2020 Oct 20.
9
Chelating Polymers for Hereditary Hemochromatosis Treatment.螯合聚合物在遗传性血色素沉着症治疗中的应用。
Macromol Biosci. 2020 Dec;20(12):e2000254. doi: 10.1002/mabi.202000254. Epub 2020 Sep 21.
10
Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.遗传性血色素沉着症的关节病与红细胞平均体积升高相关。
Scand J Rheumatol. 2021 Mar;50(2):139-142. doi: 10.1080/03009742.2020.1800081. Epub 2020 Sep 18.